These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 11910313
1. Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart. Yamamoto K, Masuyama T, Sakata Y, Nishikawa N, Mano T, Hori M. J Hypertens; 2002 Apr; 20(4):753-61. PubMed ID: 11910313 [Abstract] [Full Text] [Related]
5. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure. Kobayashi M, Machida N, Mitsuishi M, Yamane Y. Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617 [Abstract] [Full Text] [Related]
6. Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats. Nishikawa N, Masuyama T, Yamamoto K, Sakata Y, Mano T, Miwa T, Sugawara M, Hori M. J Am Coll Cardiol; 2001 Nov 01; 38(5):1539-45. PubMed ID: 11691537 [Abstract] [Full Text] [Related]
7. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function. Yamauchi-Kohno R, Miyauchi T, Hoshino T, Kobayashi T, Aihara H, Sakai S, Yabana H, Goto K, Sugishita Y, Murata S. Circulation; 1999 Apr 27; 99(16):2171-6. PubMed ID: 10217659 [Abstract] [Full Text] [Related]
8. Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Miwa T, Hori M, Masuyama T. Cardiovasc Res; 2003 Mar 27; 57(3):757-65. PubMed ID: 12618237 [Abstract] [Full Text] [Related]
9. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Yamamoto K, Masuyama T, Sakata Y, Nishikawa N, Mano T, Yoshida J, Miwa T, Sugawara M, Yamaguchi Y, Ookawara T, Suzuki K, Hori M. Cardiovasc Res; 2002 Jul 27; 55(1):76-82. PubMed ID: 12062710 [Abstract] [Full Text] [Related]
10. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system. Yamamoto K, Masuyama T, Sakata Y, Doi R, Ono K, Mano T, Kondo H, Kuzuya T, Miwa T, Hori M. Cardiovasc Res; 2000 Jun 27; 46(3):421-32. PubMed ID: 10912453 [Abstract] [Full Text] [Related]
11. Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats. Oie E, Yndestad A, Robins SP, Børnerheim R, Asberg A, Attramadal H. Basic Res Cardiol; 2002 May 27; 97(3):239-47. PubMed ID: 12061394 [Abstract] [Full Text] [Related]
13. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Circulation; 1995 May 15; 91(10):2642-54. PubMed ID: 7743628 [Abstract] [Full Text] [Related]
14. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension. Rothermund L, Vetter R, Dieterich M, Kossmehl P, Gögebakan O, Yagil C, Yagil Y, Kreutz R. Circulation; 2002 Oct 29; 106(18):2305-8. PubMed ID: 12403658 [Abstract] [Full Text] [Related]
15. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy. Chang SA, Kim YJ, Lee HW, Kim DH, Kim HK, Chang HJ, Sohn DW, Oh BH, Park YB. Hypertension; 2009 Sep 29; 54(3):591-7. PubMed ID: 19564547 [Abstract] [Full Text] [Related]
16. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats. Kobayashi N, Hara K, Higashi T, Matsuoka H. Am J Hypertens; 2000 Oct 29; 13(10):1088-96. PubMed ID: 11041163 [Abstract] [Full Text] [Related]
17. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats. Sakata Y, Masuyama T, Yamamoto K, Nishikawa N, Yamamoto H, Kondo H, Ono K, Otsu K, Kuzuya T, Miwa T, Takeda H, Miyamoto E, Hori M. Circulation; 2000 Oct 31; 102(18):2269-75. PubMed ID: 11056104 [Abstract] [Full Text] [Related]
18. Angiotensin II type 1 receptor blockade prevents diastolic heart failure through modulation of Ca(2+) regulatory proteins and extracellular matrix. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Nakayama H, Otsu K, Suzuki K, Tada M, Hori M, Miwa T, Masuyama T. J Hypertens; 2003 Sep 31; 21(9):1737-45. PubMed ID: 12923407 [Abstract] [Full Text] [Related]
19. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, Araki M, Sasayama S. Circulation; 1998 Nov 10; 98(19):2065-73. PubMed ID: 9808606 [Abstract] [Full Text] [Related]
20. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Hori M, Miwa T, Masuyama T. Circulation; 2004 May 04; 109(17):2143-9. PubMed ID: 15051632 [Abstract] [Full Text] [Related] Page: [Next] [New Search]